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Abstract We present a method to discover interesting brain regions in [18F]
fluorodeoxyglucose positron emission tomography (PET) scans, showing also
the benefits when PET scans are in combined use with non-imaging vari-
ables. The discriminative brain regions facilitate a better understanding of
Alzheimer’s disease (AD) progression, and they can also be used for predicting
conversion from mild cognitive impairment (MCI) to AD. A survival analysis
(Cox regression) and infinite Gaussian mixture model (IGMM) are introduced
to identify the informative brain regions, which can be further used to make
a prediction of conversion (in two years) from MCI to AD using only the
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baseline PET scan. Further, the predictive accuracy can be enhanced when
non-imaging variables are used together with identified informative brain vox-
els. The results suggest that PET scan imaging data is more predictive than
other non-imaging data, revealing even better performance when both imaging
and non-imaging data are combined.
Keywords Survival analysis · Cox regression · MCI conversion · PET ·
infinite Gaussian mixture model · Clustering
1 Introduction
Alzheimer’s disease (AD) is a progressive, degenerative and incurable disease
of the brain and the most prevalent cause of dementia. The number of people
suffering from dementia is expected to grow rapidly in the next decades due
to increasing life expectancy [1], which will have a major negative impact
on health care systems worldwide. Despite technological progress, the ante
mortem diagnosis of AD is still based on clinical grounds, with biomarkers such
as cerebrospinal fluid (CSF) proteins and neuroimaging procedures providing
supporting information.
Positron emission tomography with [18F] fluorodeoxyglucose (FDG-PET)
has been widely applied to assist in the diagnosis of clinical AD [6]. Accord-
ingly, FDG-PET was recommended as a diagnostic marker by recently pro-
posed guidelines [7]. One important area in which functional neuroimaging may
add significant value is the prediction progression of prodromal AD, i.e., mild
cognitive impairment (MCI), to full-blown AD dementia. A growing number
of studies show that FDG-PET can predict the clinical outcome in MCI with a
relatively high sensitivity and specificity. A recent literature review underpins
the gain in overall diagnostic accuracy by using FDG-PET in the evaluation
of dementia, supporting its role as an effective complementary tool [3]. Supe-
riority of FDG-PET to other potential predictors of clinical decline in MCI
has been suggested by some [11], but not all [8] studies. Typically, an AD-like
FDG-PET pattern with regional decreases in cerebral glucose metabolism in
posterior temporoperietal regions and the posterior cingulate cortex, as well
as to a lesser degree the prefrontal cortex, is found to be predictive of future
AD dementia in patients with MCI [15].
Despite the compelling evidence in favor of FDG-PET as a prognostic
marker, most experts concur that there is an immediate need for further efforts
to improve implementation of neuroimaging in current diagnostic paradigms,
including the optimization of the image analysis methods. Previous studies
suggest that improved analytical methods such as principal component analy-
sis [9], linear programming discriminant analysis [22], support vector machines
(SVM), Gaussian process classification [21] or tree structured sparse learning
[13] may improve the overall diagnostic and prognostic classification of pa-
tients. The main aim of the present study is of two-fold: first, to apply sur-
vival analysis and the infinite Gaussian mixture model to FDG-PET scans in
order to improve the differentiation between patients who remain in the MCI
GMM and model selection for PET classification 3
Table 1 Baseline information mean (SD) of the patients. The protocol of ADNI di-
agnostic and image acquisition is described in appendix.CDR: Clinical Dementia Rat-
ing. CDT: clock drawing test, 5 is the best score and 0 is the worst. MMSE:
Mini-Mental State Examination. ADAS: Alzheimer’s Disease Assessment Scale. The
higher the ADAS, the more severe of mental illness. More explanation is referred to
http://www.adni-info.org/scientists/Pdfs/ADNI GeneralProceduresManual.pdf
Subjects Age CDR Total CDT MMSE ADAS
(female:male)
MCIMCI 45 (13:32) 76 (8.2) 1.97 (0.3) 4.3 (0.8) 27.4 (1.6) 15 (6.6)
MCIAD 32 (12:20) 75 (6.9) 1.95 (0.3) 3.8 (1.1) 26.7 (1.7) 19 (4.6)
stage (MCIMCI) and those that progress to AD dementia (MCIAD), and sec-
ond, to investigate the usefulness of non-imaging data compared to FDG-PET
imaging data.
2 Materials and Methods
2.1 Study Participants
Experiments were performed using data of the publicly available AD Neu-
roimaging Initiative (ADNI) database (http://adni.loni.usc.edu/) accessed in
the year 2011. Only data from the first stage of ADNI (ADNI 1) were consid-
ered. ADNI has a large pool of FDG-PET (co-registered, averaged) images,
which have been acquired on various scanners using different imaging param-
eters. To eliminate bias due to these factors, we selected images that had been
obtained using the same scanner (Siemens/CTI) as well as the same parame-
ters, such as the number of slices. To ensure that differences in the degree of
cognitive impairment at baseline did not affect our results, we only included
patients with a Clinical Dementia Rating (CDR) sum of the boxes score of 1.5,
2 and 2.5 [14]. Patients were only considered if they had at least five consecu-
tive clinical assessments every six months up to a maximum of 24 months in
order to have sufficient data for the survival analysis. The planned pre-selection
of participants resulted in a total of 77 patients, including 45 MCIMCI and 32
MCIAD. MCIMCI was defined as patients not meeting the Institute of Neuro-
logical and Communicative Disorders and Stroke-AD and Related Disorders
Association (NINCDS-ADRDA) criteria for AD at their last follow-up assess-
ment, whereas MCIAD patients met the NINCDS-ADRDA criteria at least
at one of the follow-up visits. It is important to note that this is a censored
dataset, which includes patients that did not progress to AD dementia until
their last follow-up visit for various reasons including withdrawal of consent,
death or limited length of follow-up. This phenomenon is often studied using
survival analysis [10], which is also the essential technique applied in this work.
The characteristics of the study population are summarized in Table 1.
Time to progression from MCI to AD dementia was calculated as the time
between the baseline visit and the visit at which an AD dementia diagnosis
4 Rui Li et al.
was first established. As a result, we obtain a dataset that allows us to train
a model predicting progression to AD dementia within 24 months.
2.2 Image Pre-processing
Prior to their use for image analysis, the FDG-PET images underwent two
pre-processing steps in the statistical parametric mapping software package
SPM5 (Wellcome Functional Imaging Laboratory, London, UK), based on
Matlab R2010a (The Mathworks Inc, Natick, USA): spatial normalization
and smoothing (kernel size [8 8 8] mm). Spatial normalization ensures that
the processed image is of the size 91×109×91 voxels, which is in accordance
with the Anatomical Automatic Labeling (AAL) template [18]. The final step
is intensity normalization, which was done by dividing each voxel by the mean
intensity value averaged over the primary sensorimotor cortex region, which
has been shown to improve FDG-PET based discrimination compared to other
brain regions or the global metabolic mean [20]. Anatomically, the “Precen-
tral L, Precentral R, Postcentral L and Postcentral R” regions in the AAL
brain template can be used as the primary sensorimotor cortex. The analy-
sis is performed only on the AAL defined brain regions (gray matter voxels
of MNI space). In total, there are 185,405 voxels in the AAL brain template.
Among 185,405 voxels in each FDG-PET scan, there is a portion of voxels that
contain discriminative information. Hence, the following method is proposed
to discover the discriminative voxels.
2.3 Identification of discriminative Voxels
Cox regression is suitable to be applied when some censored records occur in
a dataset, which is exactly the scenario of the ADNI follow-up study (end of
study after, for example, 5 visits). Therefore, we use this technique in a first
step to select the discriminative voxels of FDG-PET scans.
2.3.1 Introduction to Cox Regression (Survival Analysis)
Cox regression is a semi-parametric survival analysis method. It makes no
assumption about the probability distribution of the survival time, assuming
only proportional hazards. Cox regression is also known as the Cox propor-
tional hazards model [5]. The rate at which the failure happens or the patient
suffers from a disease is known as the hazard function. Let x1, x2,..., xp be the
values of p covariates X1, X2,..., Xp. The hazard function is defined as:
h(t) = h0(t) exp
(
p∑
i=1
βixi
)
, (1)
where β1, β2,..., βp is the 1 × p vector of regression parameters and h0(t)
is the baseline hazard function at that time. The coefficient vectors of the
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covariates are estimated using a maximum likelihood (ML) estimate, which
is obtained by maximizing a partial likelihood function. The hazard function
focuses on failing, whereas the survivor function focuses on “surviving” given
survival up to a certain time point. The hazard function h(t) and survivor
function s(t) can be derived from each other. The general formula for their
relation is:
s(t) = exp
(
−
∫ t
0
h(u)du
)
. (2)
Since we apply Cox regression on each single voxel in this first step, we have
only one covariate β1 to determine, and x1 is the voxel intensity. Kleinbaum
[10] offers a more comprehensive introduction to survival analysis.
2.3.2 Cox Regression applied to FDG-PET
Given the baseline PET scan, we run the Cox regression on each of the 185,405
voxels (AAL defined) independently on 77 studied samples, collecting the ones
that show a negative correlation β1 with hazardness at a p-value smaller than
0.01 (i.e., voxels that correlate positively with the survival time). The statis-
tical significance level of 0.01 instead of 0.05 is chosen because we apply no
multiple comparisons correction. The reason why we did not perform multiple
comparisons correction is that too many voxels may be discarded after cor-
rection. The resulting voxels are first filtered out in this way, before they are
combined in a classification model (see below).
2.3.3 Selection of neighboring Voxels by Infinite Gaussian Mixture Model
A number of discriminative (informative) voxels are identified by the Cox
regression analysis. Since an informative voxel’s neighboring voxels also tend
to be informative (in part due to the partial volume effect [17], we need to
eliminate such an effect to avoid overfitting. We therefore applied the infinite
Gaussian mixture model to divide the voxels into clusters based on their x, y,
and z coordinates (the resulting clusters are illustrated in Fig. 1).
The infinite Gaussian Mixture Model (IGMM) [16] was proposed as an
extension of the widely applied Gaussian Mixture Model (GMM) [2]. In a
GMM, the number of clusters (components) is assumed to be fixed a priori,
which is, in fact, hard to do in practice. On the contrary, IGMM assumes
the number of clusters is unknown (infinity, not to limit the number), which
is determined by the data in the end. The IGMM can be briefly written as
follows:
p(x|θ) =
K∑
k=1
pikN (x;µk,Σk), (3)
6 Rui Li et al.
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Fig. 1 Illustration of significant voxels and the clustering results. (a): 3D view of the same
voxels shown in 2D. (b): 3D view of significant voxels after Cox regression. (c): 2D view of
clustered voxels (same color represents same cluster) after applying the infinite Gaussian
mixture model. (d): 3D view of the same voxels shown in subplot (c). (e): 2D view of selected
10% voxels shown in subplot (c) and (d). (f): 3D view of the same voxels shown in subplot
(e).
where µk, Σk and pik are the mean, covariance and mixing proportion
respectively. In addition, ΣKk=1pik = 1, pik ≥ 0 and θ = {µk,Σk, pik}. N denotes
the D-dimensional Gaussian distribution:
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Fig. 2 Workflow of proposed MCI conversion prediction. IGMM: infinite Gaussian mixture
model.
N (X |µ,Σ) =
1
(2pi)
D
2 |Σ|
1
2
exp
(
−
1
2
(X − µ)TΣ−1(X − µ)
)
. (4)
By allowing K → ∞, IGMM extends the GMM in terms of the number
of clusters. The inference is achieved by Markov chain Monte Carlo (MCMC),
performing Gibbs sampling for a number of iterations. In the end, the voxel
data neighbouring each other are likely to be grouped in one cluster.
After applying IGMM, the clustered voxels in one cluster are adjacent to
each other. We subsequently chose 10% of the voxels in each cluster to rep-
resent the respective cluster, selecting voxels spread widely across the cluster.
Finally, we collected the chosen 10% of voxels in every cluster as the discrimi-
native voxels for the prediction model. In our experiments, 10% is empirically
shown to be optimal. The reason may be that, too few voxels, such as 1%,
may exclude some discriminative ones hence causing underfitting. On the other
hand, too many voxels, such as 50% may still cause overfitting. Another reason
is that the complementary information conveyed by other non-imaging data
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(see Section “Building the Classification Model”) cannot be fully used, due to
curse of dimensionality, if too many voxel features are selected in building the
classification model. The workflow is depicted in Fig. 2.
2.4 Building the Classification Model
The identified imaging voxels were used as features to build a classification
model. In this study, we employed support vector machines (SVM), which is
a state-of-the-art classifier. LIBSVM [4] was used to build the SVM models
with a linear kernel with grid search for parameter optimization. Grid search
considers only the optimization of the penalty parameter in the linear SVM,
selecting the value that yields the best classification result based on the train-
ing data. After the best value is found, it is applied to the test data. To
validate the model, the whole dataset was split into two subsets, a training
set used for model building and a test set used to test the performance of
the model. A 5-fold cross-validation was applied to split the data, which was
achieved by dividing it into five disjoint subsets, with four subsets as train-
ing and the remaining subset as test dataset. In addition to the imaging data
(FDG-PET), we also investigated the non-imaging data (cf. Table 1) with
the aim to consider information derived from more than just one source or
modality. The non-imaging data includes age, gender, the results of the Clock
Drawing Test (CDT), the Mini-Mental State Examination (MMSE) and the
Alzheimer’s Disease Assessment Scale (ADAS). Note that we did not use the
Clinical Dementia Rating (CDR) in building the model, because CDR is a
stronger indicator used for the diagnosis.
3 Results
The study samples show that the number of males is greater than the number
of females in both MCIMCI and MCIAD (cf. Table 1). The two groups of
MCIMCI and MCIAD indicate similar average age and CDR at baseline. Other
cognitive indicators, such as CDT, MMSE, ADAS, all suggest that the MCIMCI
group is at a better cognitive status than MCIAD.
3.1 Brain Voxels identified by Cox Regression Analysis
After applying a Cox regression analysis, a number of discriminative voxels
served as essential features to train the subsequent model. Some identified
voxels are displayed in Fig. 3. Table 2 reveals these voxels’ associated regions
defined in the AAL template. The “Precuneus L, Precuneus R, Parietal Inf L
and Angular R” account for particularly high percentages compared to other
regions. It is known that the precuneus is involved in several essential cognitive
tasks. For example, episodic memory, visual-spatial abilities, and motor activ-
ity coordination strategies. The parietal lobe includes symbolic functions in
GMM and model selection for PET classification 9
Fig. 3 2D view of the interesting regions at the 45th layer based on the whole dataset
using Cox regression at a p-value of 0.01 (a): coronal view (b): sagittal view (c): transaxial
view. x, y and z are the width (91), depth (109) and height (91) respectively. The red points
represent the informative voxels (brain regions).
Table 2 The top-10 interesting regions and their proportions using the whole dataset. The
proportion is calculated as the number of significant voxels in the region divided by the
number of total significant voxels. Region name is referred to AAL template [18].
Regions Percentage Regions Percentage
1: Precuneus L 13.9% 6: Temporal Mid L 5.79%
2: Precuneus R 11.3% 7: Parietal Sup R 5.05%
3: Parietal Inf L 10.8% 8: Parietal Inf R 4.71%
4: Angular R 10.3% 9: Parietal Sup L 3.84%
5: Angular L 7.78% 10: Cingulum Mid R 3.57%
language and numbers and interpretation of spatial information. The remain-
ing identified regions, such as angular, temporal and cingulum, are associated
with some cognitive abilities as language, mathematics and memory, etc.
3.2 Prediction of Progression to AD Dementia
The baseline accuracy of random guessing is at 45/(45+32) = 58.4% (45
MCIMCI and 32 MCIAD) to predict that a patient does not progress to AD
dementia within two years. Fig. 4 demonstrates that the FDG-PET scan alone
achieves a classification accuracy of 70%, which is higher than the accuracy
of any other information source. Classification accuracy reaches nearly 80%
when all the sources of information are pooled together to build the predictive
model, the reason being that the model benefits from gaining complementary
discriminative information from diverse sources.
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Fig. 4 Comparison of classification accuracy of various information sources. All: using all
data (PET, ADAS, MMSE, Demo, ApoE and CDT) as features in SVM. ApoE: Apolipopro-
tein E.
4 Discussion
Accurately predicting the course of MCI is an important clinical and academic
aim, but censored data often limit the ability to derive meaningful results.
Survival analysis is a suitable statistical tool for this kind of situation since it
allows to analyze incomplete datasets. The current study corroborates findings
of previous studies, showing that a metabolic deficit in the temporoparietal
cortex, the precuneus and the limbic cortex offer valuable information in terms
of dementia risk in MCI [15]. These brain areas are well known to play a role
in episodic memory, visuospatial processing and executive function, which all
are typically affected early in the course of AD [19]. Our results also show that
survival analysis is a viable statistical method to discriminate between progres-
sive and stable MCI cases. The usual limitations of studies based on clinical
cohorts recruited at specialized memory clinics apply to our study. These in-
clude the lack of generalizability of the results to the wider population due
to highly selected MCI patients with a high a priori probability of suffering
from AD; the lack of histopathological verification of the clinical diagnoses;
the limited follow-up period; and the restricted sample size. We also demon-
strate the benefits of a clustering algorithm (IGMM) to cluster the significant
voxels derived from the Cox regression model. These voxels can be clustered
into different groups with respect to their geometric similarity. By choosing a
portion (i.e., 10%) of the voxels in each cluster, we avoid using too many voxels
and thereby effectively reduce the risk of overfitting, while still maintaining
informative voxels for dementia prediction. We also corroborate the view that
combining imaging data with neurocognitive and demographical information
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leads to improved classification accuracy. To combine various sources of data,
one may also use multi-view stacking [12]. However, the present research does
not benefit from it because of the limited classification performance of non-
imaging variables. In our case, collecting all data into a simple form for learning
yields satisfactory results. The improvement in accuracy can be attributed to
the complementary information provided by non-imaging variables, in other
words, more complementary information sources together benefit the training
model.
5 Conclusions
The present study proposes a survival analysis method to analyze neuroimag-
ing data to gain insights into the ability of FDG-PET to predict conversion
from MCI to AD dementia within 24 months. By treating data from patients
not progressing to AD dementia as censored records, we were able to use
survival analysis to detect the brain regions that convey discriminative in-
formation. This approach revealed brain regions that are typically associated
with early clinical AD and can be used to predict progression in MCI. The
use of IGMM divides the discriminative voxels into various clusters, coping
with overfitting by selecting a portion of voxels. Less discriminative power is
conveyed by the neurocognitive and demographical data, which however still
seem to provide complementary information, which altogether improves the
prediction model. To conclude, our study describes the application of robust
statistical methods to FDG-PET data analysis that may improve the use of
neuroimaging data for the characterization of MCI in prospective research
settings.
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Appendix: ADNI Diagnostic and Image Acquisition Protocol
The ADNI recruitment and inclusion procedures are described in detail
at www.adni-info.org. Briefly, at baseline, subjects in ADNI were between
55−90 years of age, had a modified Hachinski score ≤ 4 and at least six years
of education. Patients with MCI had MMSE scores between 24 and 30, a
CDR score of 0.5; they had memory complaints, but no significant functional
impairment, and objective memory deficits on the Wechsler Memory-Scale-
Logical Memory II test. After the baseline visit, follow-up visits were conducted
at six- or 12-month intervals up to a maximum of six years. FDG-PET were
acquired within two weeks before or two weeks after the in-clinic assessments
at Baseline and at the second annual visit, 24 months after Baseline.
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